Herpes Zoster Vaccine Approved in Japan by GSK
The Japanese Ministry of Health, Labor and Welfare (MHLW) has indicated a new indication for GlaxoSmithKline’s (GSK) herpes vaccine Shingrix (recombinant herpes vaccine, adjuvanted [RZV]). This vaccine is for adults 18 years of age and older who are most at…